









Markets
/
Stocks
/
nasdaq-ttrx
/

Turn Therapeutics Ord Shs

TTRX

3.370USD

-0.940-21.81%

Close 12/08, 16:00（ET）Quotes delayed by 15 min

--Market Cap

LossP/E TTM



Turn Therapeutics Ord Shs

3.370

-0.940-21.81%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Turn Therapeutics Ord Shs to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---588.61K

Net income from continuing operations

---1.90M

Operating gains losses

--13.68K

Other non-cash items

--292.00

Change in working capital

--1.26M

-Change in prepaid expenses

--15.44K

-Change in payables and accrued expense

--1.25M

Cash from non-recurring investing activities

Cash from operating activities

---588.61K

Investing cash flow

Net cash from continuing investing activities

--89.79K

Capital expenditures

--89.79K

Net cash flow from intangible asset transactions

--89.79K

Cash from non-current investing activities

Net cash flow from investing activities

---89.79K

Financing cash flow

Cash flow from continuous financing activities

--594.62K

Net cash flow from common stock issuance/repurchase

--594.62K

Net cash from non-recurrent financing activities

Net cash from financing activities

--594.62K

Net cash flow

Beginning cash balance

--3.19M

Current period cash flow changes

---83.79K

Ending cash balance

--3.11M

Free cash flow

---678.40K

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

